+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

TCT-671 Clinical impact of periprocedural myocardial infarction according to various definitions in patients underwent percutaneous coronary intervention with drug eluting stent



TCT-671 Clinical impact of periprocedural myocardial infarction according to various definitions in patients underwent percutaneous coronary intervention with drug eluting stent



Journal of the American College of Cardiology 70(18): B293-B294




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 065056877

Download citation: RISBibTeXText

DOI: 10.1016/j.jacc.2017.09.919


Related references

Comparison of clinical outcomes according to presentation of angina pectoris versus acute myocardial infarction in patients who underwent a percutaneous coronary intervention with a drug-eluting stent. Coronary Artery Disease 27(2): 143-150, 2016

Impact of admission creatinine level on clinical outcomes of patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention with drug-eluting stent implantation. Chinese Medical Journal 121(23): 2379-2383, 2009

Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry. Jacc. Cardiovascular Interventions 2(11): 1074-1082, 2010

AS-62: Midterm Clinical Outcomes of ST Elevation Myocardial Infarction versus Non-ST Elevation Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stent. American Journal of Cardiology 103(9-Supp-S): 30-31, 2009

Five-year major clinical outcomes between first-generation and second-generation drug-eluting stents in acute myocardial infarction patients underwent percutaneous coronary intervention. Journal of Geriatric Cardiology 15(8): 523-533, 2018

Incidence, predicting factors, and clinical outcomes of periprocedural myocardial infarction after percutaneous coronary intervention for chronic total occlusion in the era of new-generation drug-eluting stents. Catheterization and Cardiovascular Interventions 92(3): 477-485, 2017

First results of the DEB-AMI (drug eluting balloon in acute ST-segment elevation myocardial infarction) trial: a multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in primary percutaneous coronary intervention with 6-month angiographic, intravascular, functional, and clinical outcomes. Journal of the American College of Cardiology 59(25): 2327-2337, 2012

Long-term clinical outcome in patients with peripheral arterial disease underwent percutaneous coronary intervention with drug-eluting stent. European Heart Journal 34(Suppl 1): P3370-P3370, 2013

Usefulness of preprocedure high-sensitivity C-reactive protein to predict death, recurrent myocardial infarction, and stent thrombosis according to stent type in patients with ST-segment elevation myocardial infarction randomized to bare metal or drug-eluting stenting during primary percutaneous coronary intervention. American Journal of Cardiology 107(11): 1597-1603, 2011

AS-144 Impact of Routine Follow Up Coronary Angiography on 2-Year Clinical Outcomes in Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents. American Journal of Cardiology 107(8-Supp-S): 41-0, 2011

AS-85: Early and Midterm Clinical Outcomes of Single versus Multiple Lesions in Patients with Acute ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention with Drug-eluting Stent. American Journal of Cardiology 103(9-Supp-S): 39-40, 2009

AS-135 Incidence of Tachyarrhythmia and its Impact on Two-Year Clinical Outcomes in Patients with ST Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents. American Journal of Cardiology 107(8-Supp-S): 38-0, 2011

Gender difference in patients with acute myocardial infarction treated by primary percutaneous coronary intervention in drug-eluting stent era. Chinese Medical Journal 123(7): 776-777, 2010

Sex-specific benefits of sirolimus-eluting stent on long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: insights from the Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study trial. American Heart Journal 163(1): 104-111, 2012

Periprocedural (30-day) risk of myocardial infarction after drug-eluting coronary stent implantation: a meta-analysis comparing cobalt-chromium and stainless steel drug-eluting coronary stents. Eurointervention 6(8): 1003-1010, 2011